Skip to main content
. 2022 Dec 30;12(1):e025666. doi: 10.1161/JAHA.122.025666

Figure . Prespecified analysis of subgroups at high risk of bleeding for BARC 2, 3, or 5 access site bleeding at day 3.

Figure .

No BARC 3 or 5 access site bleeding at day 3 was reported in the trial. BARC indicates Bleeding Academic Research Consortium; and VCD, vascular closure device.